These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6831482)

  • 1. Effect of intermittent and continuous administration of L-cysteine hydrochloride on L1210 mouse leukemia.
    Knight T; Besa EC; Joseph RR; Baskin SI
    Cancer Treat Rep; 1983 Mar; 67(3):319-20. PubMed ID: 6831482
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronomodulatory effect of cyclosporine upon survival of DBA mice with L1210 leukemia.
    Sánchez de la Peña S; Halberg E; Halberg F; Sánchez E; Cornélissen G
    Chronobiologia; 1986; 13(2):129-35. PubMed ID: 3731947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of schedule of administration of mitomycin C (NSC-26980) in the treatment of L1210 leukemia.
    Kojima R; Goldin A; Mantel N
    Cancer Chemother Rep 2; 1972 Nov; 3(1):111-9. PubMed ID: 4660730
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.
    Auletta AE; Gery AM; Mead JA
    Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor effects of ribavirin on L1210 leukemia in the DBA/2 mouse.
    Jolley WB; Chu WT; Salter JM; Hinshaw DB; Randhawa AS
    Ann N Y Acad Sci; 1977 Mar; 284():585-90. PubMed ID: 280149
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of pentagastrin administration on survival of mice with L1210 leukemia.
    Armata J; Srebo Z; Stankiewicz D; Wiliński B
    Cancer Treat Rep; 1983 Apr; 67(4):408. PubMed ID: 6850660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of diazan on DNA, RNA, and protein synthesis in mouse L1210 leukemia cells sensitive and resistant to the drug].
    Anikin IV; Kukushkina GV; Sokolova IS; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1981; (2):291-5. PubMed ID: 7240552
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of "3-oxauracil" (2,3-dihydro-1,3-6H-oxazine-dione) in L1210 leukemia.
    Ujházy V; Reiner P; Farkas J; Skoda J
    Neoplasma; 1977; 24(3):259-61. PubMed ID: 895936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of lipoic acid and doxorubicin in murine leukemia.
    Dovinová I; Novotný L; Rauko P; Kvasnicka P
    Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
    Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ
    J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
    [No Abstract]   [Full Text] [Related]  

  • 12. Single versus combination chemotherapy of L1210 leukemia.
    Koza I; Balázová E; Ujházy V
    Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
    Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
    Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide].
    Kudriavtsev IA; Paramonova TD; Golenko OD; Miasishcheva NV
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):27-31. PubMed ID: 7122454
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of benzyl penicillin on cytotoxicity and level of metabolic activity of cyclophosphamide in mice].
    Pakulska W; Graczyk J
    Acta Pol Pharm; 1993; 50(2-3):159-63. PubMed ID: 8030423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumoral activity of patulin and patulin-cysteine adducts.
    Krivobok S; Seigle-Murandi F; Steiman R; Benoit-Guyod JL; Bartoli MH
    Pharmazie; 1994 Apr; 49(4):277-9. PubMed ID: 8197228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
    Scheving LE; Burns ER; Pauly JE; Halberg F
    Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of biological response modifier sulfoethylated (1 --> 3)-beta-D-glycan on the experimental leukemia in mice].
    Khalikova TA; Korolenko TA
    Eksp Klin Farmakol; 2006; 69(5):39-43. PubMed ID: 17153965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.